Presentations

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

October 21, 2019

Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies

September 23, 2019

Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration

August 1, 2019

CPP 3DT Regulatory Interaction Summary August 2019

June 25, 2019

Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials

June 3, 2019

Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan

May 22, 2019

Measurement Comparability of Electronic and Paper Administered Visual Analogue Scales: A Review of Published Studies

May 1, 2019

Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA

April 5, 2019

Muscular Dystrophy Association 2019 Clinical and Scientific Conference

Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or

March 17, 2019

Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA

February 19, 2019

Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA

Previous78 9...14 Next